On Thursday, May 9, the Affordable Prescriptions for Patients (APP) Act was introduced into the U.S. Senate by…
Intellectual property (IP) is a pharmaceutical or biotech company’s most valuable resource, and its protection…
European parliament approves SPC manufacturing waiver – In its final plenary session prior to the EU elections…
Alembic has recently entered into a Joint Venture Agreement (JVA) with SPH SINE Pharmaceutical Laboratories, C…
Brexit: a quick refresher. We have now passed 29 March 2019 – the day when, absent any extension, the UK was s…
Munich, 12 March 2019 – UK businesses again continued to file a growing number of patent applications with the…
The University of California announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Pat…
Under his command, the FDA took quick and decisive action on drug costs. The commissioner worked to boost gene…
The Indian Pharmaceutical Alliance (IPA), the lobby group for the domestic pharma industry, has filed a submis…
We are glad to inform you 4th China Pharma IP Summit 2019 is officially launched. This year the event will be …
